Molly Maloy - Concepedia

Author

Molly Maloy

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

M A Maloy, M Maloy, M. Maloy, M.A. Maloy, Molly A Maloy, Molly A. Maloy, Molly A. Maloy, MS, Molly Maloy

264

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University Instituto de Investigación Marqués de Valdecilla The University of Texas MD Anderson Cancer Center Universitat Autònoma de Barcelona

About

Molly Maloy is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	847
2	Health Sciences	3	3	82
3	Public Health	2	2	75
4	Biomedical Engineering	2	2	22
5	Allergy	1	1	135

Molly Maloy

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation Jonathan U. Peled, Antonio L. C. Gomes, Sean M. Devlin, New England Journal of Medicine	2020	676
Lactose drives <i>Enterococcus</i> expansion to promote graft-versus-host disease Christoph K. Stein‐Thoeringer, Katherine Nichols, Amina Lazrak, Science	2019	334
Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation Jonathan U. Peled, Sean M. Devlin, Anna Staffas, Journal of Clinical Oncology	2017	315
Chemotherapy and COVID-19 Outcomes in Patients With Cancer Justin Jee, Michael B. Foote, Melissa Lumish, Journal of Clinical Oncology	2020	263
Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies Tania Jain, Andrea Knežević, Martina Pennisi, Blood Advances	2020	252
Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma Kitsada Wudhikarn, M. Lia Palomba, Martina Pennisi, Blood Cancer Journal	2020	249
Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells Martina Pennisi, Miriam Sánchez‐Escamilla, Jessica Flynn, Blood Advances T-regulatory CellImmune RegulationImmunologyEndothelial ActivationImmune System	2021	173
Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management Martina Pennisi, Tania Jain, Bianca Santomasso, Blood Advances	2020	145
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD Kate A. Markey, Jonas Schlüter, Antonio L. C. Gomes, Blood	2020	141
DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality Kitsada Wudhikarn, Martina Pennisi, Marta García‐Recio, Blood Advances Clinical ImmunologyLow Nonrelapse MortalityImmunotoxicologyImmunodeficienciesImmunology	2020	135

Page 1